Document is current
Any future updates will be listed below
-
Authors
Van Hemelryck, Sandy https://orcid.org/0000-0002-0103-8225
Van Landuyt, Erika
Ariyawansa, Jay
Palmer, Martyn
Kothe, Martine J. C.
Pollefliet, Caroline
-
Funding
Funding for this research was provided by:
Janssen Research & Development
- License Information
-
More Information
Article History
Received: 29 August 2023
Accepted: 6 June 2024
First Online: 14 October 2024
Declarations
:
: Although these data are not currently publicly available for sharing, requests for sharing can be sent to the corresponding author and will be evaluated on an individual basis.
: SVH, EVL, JA, MP, MJCK, and CP are employees of Janssen and may be stockholders of Johnson & Johnson.
: This study was sponsored and funded by Janssen Research & Development. Janssen Research & Development had a role in the conceptualization, design, data collection, analysis, decision to publish, and preparation of this manuscript.
: This study was sponsored by Janssen Research & Development. The authors thank Vera Hillewaert, of Janssen Pharmaceutica NV, for bioanalysis support. Medical writing support was provided by Melanie Chen, PharmD, of Lumanity Communications Inc., and was funded by Janssen Scientific Affairs.
: Not applicable.
: This study was conducted in accordance with Good Clinical Practice following the principles of the Declaration of Helsinki, with protocol approval by Comité voor medische ethiek UZA and written informed consent obtained from participants.
: Not applicable.
